Proactiveinvestors recommends
Additional Information
Market: AIM
Sector: Technology Hardware & Equipment
EPIC: AMP
Latest Price: 4.63p  (2.89% Ascending)
52-week High: 7.50p
52-week Low: 2.25p
Market Cap: 6.24M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Amphion Innovations
www.amphionplc.com

Amphion builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.

Amphion has a significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

Full Amphion Innovations profile here
Pdf

Amphion investee Kromek wins US$0.4 million award from Global Security Challenge

18th Nov 2009, 10:21 am Amphion investee Kromek wins US$0.4 million award from Global Security Challenge

IP commercialisation company Amphion Innovations (AIM: AMP) has announced that its portfolio company Kromek has won yet another award, winning the title of the Security SME (small and medium sized enterprises) of 2009 at the Global Security Challenge competition in London.


The global finals were held at the London Business School and attended by worldwide security professionals, venture capitalists and industry representatives. The event was sponsored among others by Smiths Detection, BAE Systems (LSE: BA) and Accenture.


Within the best SME category, the GSC looks for businesses that develop technologies that cover the demands of public security, including technologies that provide governments, businesses and communities with technology to defend against terrorist and other attacks.


More than 200 companies participated in the competition, with Kromek winning the Western European GSC competition to advance to the finals where it defeated finalists from Australia, the US and Spain.


“The award represents an important validation for Kromek's technology and a valuable boost to our funding, which will help to develop our range of security products. Winning this category reflects the extent to which the company is pushing technological boundaries and setting a pace for the industry, worldwide,” said Chief Executive of Kromek Amab Basu.


Kromek specialises in making semiconductor materials within the Cadmium Telluride family, also supplying x-ray imaging packages with multi-view capabilities, providing real 3D x-ray imaging without specialist viewing equipment.


The company’s most recent award came last month, when Chief Executive Amab Basu was named The Ernst & Young Entrepreneur of the Year. Kromek has drawn praise for “breaking boundaries and solving problems which others have tried to solve over many years” by developing an x-ray technology which can distinguish dangerous chemicals form other similar looking liquids. Failed bombings of transatlantic flights with liquid explosives by al-Quaeda inspired terrorists back in 2006 led to the introduction of enhanced security measures which are estimated to have cost British airlines and airports £100 million.


Amphion holds a 19.99% stake in Kromek.

Its other investments include Firestar Software (15.3%), Axcess International (8.5%), Motif Biosciences (38.5%), MSA Holdings B.S.C. (50%), M2M Imaging Corp (24.4%), Myconostica (22%), Private Markets (25%), WellGen (14.6%), and DataTern (100%).

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.